HLA-DR: Molecular Insights and Vaccine Design

Molecular Analysis of Thymopentin Binding to HLA-DR Molecules

Thymopentin (TP5) triggers an immune response by contacting with T cells; however the molecular basis of how TP5 achieves this process remains incompletely understood. According to the main idea of immunomodulation, we suppose that it would be necessary for TP5 to form complex with human class II major histocompatibility complex DR molecules (HLA-DR) before TP5 interacts with T cells. The uptak...

Molecular structure and vaccine design.

CONTENTS PERSPECTIVES AND OVERVIEW .............................•...................... ........... . . ................ . . . .... 70 The Molecules: a Brief Review . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70 Two Strategies . . . . . . . . . . . . . . . . . . . . . . . . . . ...

Non-HLA antigens and HLA-DR matching in corneal transplantation.

Novel Glycosylation of HLA-DR

HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.

The MHC is central to the adaptive immune response. The human MHC class II is encoded by three different isotypes, HLA-DR, -DQ, and -DP, each being highly polymorphic. In contrast to HLA-DR, the intracellular assembly and trafficking of HLA-DP molecules have not been studied extensively. However, different HLA-DP variants can be either protective or risk factors for infectious diseases (e.g. he...